Vantage Oncology Raises $22.5 Million

Vantage Oncology Inc., an El Segundo, Calif.-based owner and operator of radiation oncology centers, has raised $22.5 million in Series D funding, according to a regulatory filing. Camden Partners was joined by return backers New Enterprise Associates, Conning Capital Partners, Versant Ventures and Salix Ventures. www.vantageoncology.com< ?xml:namespace prefix = o ns = "urn:schemas-microsoft-com:office:office" />